Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
about
An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validationGenetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humansGenome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial.Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systemsEndothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.Gene Variant of the Bradykinin B2 Receptor Influences Pulmonary Arterial Pressures in Heart Failure Patients.The endothelium: influencing vascular smooth muscle in many ways.In vivo bradykinin B2 receptor activation reduces renal fibrosis.Bradykinin promotes migration and invasion of human immortalized trophoblasts.The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease.Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin systemThe ADP receptor P2Y(1) mediates t-PA release in pigs during cardiac ischemia.Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.Angiotensin-converting enzyme inhibition alters the inflammatory and fibrinolytic response to cardiopulmonary bypass in children.Human plasma kallikrein-kinin system: physiological and biochemical parametersEndogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysisEndothelial biology in the post-menopausal obese womanDifferent cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems.Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells.Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.Icatibant.Global assays of fibrinolysis.3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression.The Effects of the Contact Activation System on Hemorrhage.Neuroprotective effect of kinin B1 receptor activation in acute cerebral ischemia in diabetic mice.Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man.In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases.The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.Short-term effects of exogenous angiotensin II on plasma fibrinolytic balance in normal subjects.Agonist-dependent variablity of contributions of nitric oxide and prostaglandins in human skeletal muscle.Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb.The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance.Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
P2860
Q24804221-12C9CDB3-1E48-4153-8016-BFAA7C59C238Q28385730-AEA76121-1794-40CE-A14D-5F5C6FA5E177Q28658007-65FCD964-DB44-4079-B2ED-057AA422C060Q30886019-796E5DC9-12D7-4409-83A1-6D97E5733EB7Q33574874-28BAC243-091D-400A-BB89-835D5D652FD9Q33652707-322BF546-E0B2-4ECC-88C4-D9A69E28BA2AQ33697706-84CF6FDE-7525-4692-A6A0-954B83CF45E8Q34111633-E4226C1B-F001-4291-9E03-137B3F938C26Q34201895-C394C3CB-1AFF-40F7-B173-3FB4E22BCCC0Q34638538-29BB791A-57FD-4239-B291-170627AD78CFQ34795075-C2BAFF38-7D67-4F55-AE62-51316FA9004DQ35122161-69082545-F0C5-4305-A79F-35005138CDA8Q35148421-C9F51CF5-616F-472B-902C-126701AD7044Q35658814-68F471FE-B9C3-41A0-98C0-F3DD78AFDDA9Q35771254-F8CC43E7-87A3-444E-B603-2A72DB5FECB4Q35928293-3ADDF80E-EFA5-4149-A250-66B5395338E7Q36171831-4928875D-3796-4BA2-AE09-4CA96CEB3B7DQ36191584-971B772F-D350-4FA1-BD2D-0683FE53F4C1Q36323673-C9993B1B-6722-4960-9966-D9250F727589Q36851259-B6033E5A-0C1F-4658-86C4-102A32DE2572Q36948682-5CC2CFE8-8CD4-4632-A9B1-0C8FB931E3B7Q36998879-37E24BBC-1418-4782-874D-AFF070144AEEQ37367707-29AFC1E6-2BE5-4793-82C8-777F237252DBQ37600721-F5FAB22A-7F69-44D1-B29D-4092F09AF3B0Q38079544-18567FA6-84F7-4125-AFE5-006EA2A603FAQ38358080-D44CEEE8-752B-4295-B2E1-2D4B42B5DF03Q39224534-AEFF91FA-65D0-420D-8F74-18CE3BBCF905Q39293906-5FFA8DC5-C565-4F00-B5EF-0716D98ACBA6Q39301841-6DD45EE3-7A72-4B7B-A673-00BC8BADFD93Q40376651-3BB1F3BC-355B-4DBA-9B65-8A307720E089Q41171782-2D2898C1-D2C3-4A6B-AB1B-BC66062B2A72Q41529359-3A60971C-DA99-4775-81BA-68FE0254BD04Q42257252-3784A747-EBEC-4BA1-820C-2DCA8B2FA544Q43093595-73A2EF12-3D74-4B12-BD21-870188906925Q43634793-55142862-30D6-4E64-A32C-7BA26BCC02BFQ44786125-A39B4F5E-B45F-4C08-A148-E75CBF001C21Q45162665-B6607B74-9227-450C-952D-4182DE390AA7Q45720876-4FF50A1E-6847-4AC5-9747-63F26C9B30A3Q46407151-2178291E-22AF-4176-8892-7C365B685798Q46569734-33251530-A81E-49F7-AC2A-A4988437CA2B
P2860
Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Bradykinin stimulates tissue p ...... oxygenase-independent pathway.
@en
Bradykinin stimulates tissue p ...... oxygenase-independent pathway.
@nl
type
label
Bradykinin stimulates tissue p ...... oxygenase-independent pathway.
@en
Bradykinin stimulates tissue p ...... oxygenase-independent pathway.
@nl
prefLabel
Bradykinin stimulates tissue p ...... oxygenase-independent pathway.
@en
Bradykinin stimulates tissue p ...... oxygenase-independent pathway.
@nl
P2093
P1433
P1476
Bradykinin stimulates tissue p ...... oxygenase-independent pathway.
@en
P2093
P304
P356
10.1161/01.CIR.102.18.2190
P407
P577
2000-10-01T00:00:00Z